Sequenom s Q3 Revenues Soar to $2.8M on Sale of 5 New Systems | GenomeWeb

NEW YORK, Nov 1 – Sequenom reported a surge in third-quarter revenues Wednesday, due to continued sales of its MassArray high-throughput SNP scoring systems and related products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.